Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1Hyperuricemia 1Gout 1Cardiovascular Diseases 1Arthritis 1

Interventions

sofosbuvir-velpatasvir drug combination 1amlodipine, atorvastatin drug combination 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Vitamin B 6 1Vitamin B 12 1Tumor Necrosis Factor Inhibitors 1Rosuvastatin Calcium 1Progesterone 1Omeprazole 1Naproxen 1Liraglutide 1Gonadotropin-Releasing Hormone 1Geritol 1Folic Acid 1Febuxostat 1Estradiol 1Colchicine 1Cholecalciferol 1Chocolate 1Atorvastatin 1Antirheumatic Agents 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cardiovascular Diseases × Colchicine × Clear all
NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed
196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡